163 related articles for article (PubMed ID: 25404440)
21. Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression.
Ise H; Nikaido T; Negishi N; Sugihara N; Suzuki F; Akaike T; Ikeda U
Am J Pathol; 2004 Aug; 165(2):501-10. PubMed ID: 15277224
[TBL] [Abstract][Full Text] [Related]
22. Detection of surface asialoglycoprotein receptor expression in hepatic and extra-hepatic cells using a novel monoclonal antibody.
Park JH; Kim KL; Cho EW
Biotechnol Lett; 2006 Jul; 28(14):1061-9. PubMed ID: 16799763
[TBL] [Abstract][Full Text] [Related]
23. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test.
Lam CM; Fan ST; Lo CM; Wong J
Br J Surg; 1999 Aug; 86(8):1012-7. PubMed ID: 10460635
[TBL] [Abstract][Full Text] [Related]
24. Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma.
Cucchetti A; Siniscalchi A; Ercolani G; Vivarelli M; Cescon M; Grazi GL; Faenza S; Pinna AD
Ann Surg; 2007 Jun; 245(6):902-8. PubMed ID: 17522516
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for postoperative liver failure after hepatectomy for hepatocellular carcinoma.
Maeda Y; Nishida M; Takao T; Mori N; Tamesa T; Tangoku A; Oka M
Hepatogastroenterology; 2004; 51(60):1792-6. PubMed ID: 15532828
[TBL] [Abstract][Full Text] [Related]
26. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients.
Noguchi T; Imai T; Mizumoto R
Hepatogastroenterology; 1990 Apr; 37(2):165-71. PubMed ID: 2160419
[TBL] [Abstract][Full Text] [Related]
27. Immediate postoperative Fibrosis-4 predicts postoperative liver failure for patients with hepatocellular carcinoma undergoing curative surgery.
Wang H; Li L; Bo W; Liu A; Feng X; Hu Y; Tian L; Zhang H; Tang X; Zhang L; Zhang M
Dig Liver Dis; 2018 Jan; 50(1):61-67. PubMed ID: 29054394
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of oral glucose tolerance test in the assessment of reserved function of liver for patients with hepatocellular carcinoma].
Wen T; Zheng G; Meng X; Chen L
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):197-200. PubMed ID: 10683934
[TBL] [Abstract][Full Text] [Related]
29. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma.
Yamamoto K; Takenaka K; Matsumata T; Shimada M; Itasaka H; Shirabe K; Sugimachi K
Hepatogastroenterology; 1997; 44(14):514-8. PubMed ID: 9164528
[TBL] [Abstract][Full Text] [Related]
30. [Two-stage multivariant analyses for prediction of hepatic function reserve].
Lu MD; Huang JF; Peng BG
Zhonghua Wai Ke Za Zhi; 1994 Dec; 32(12):745-8. PubMed ID: 7774427
[TBL] [Abstract][Full Text] [Related]
31. [Preoperative evaluation of hepatic functional reserve for patients with primary liver carcinoma].
Yuan Y; Li G; Li J
Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):377-80. PubMed ID: 8697981
[TBL] [Abstract][Full Text] [Related]
32. Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma.
Ishikawa A; Fukao K; Tsuji K; Osada A; Yamamoto Y; Ohtsuka M; Tanaka E
J Gastroenterol Hepatol; 1993; 8(5):426-32. PubMed ID: 8218989
[TBL] [Abstract][Full Text] [Related]
33. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma.
Ohwada S; Kawate S; Hamada K; Yamada T; Sunose Y; Tsutsumi H; Tago K; Okabe T
Br J Surg; 2006 Mar; 93(3):339-46. PubMed ID: 16498606
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of ascites after hepatectomy for patients with hepatocellular carcinoma and hepatitis B virus-associated cirrhosis.
Chen LP; Li C; Wang C; Wen TF; Yan LN; Li B
Hepatogastroenterology; 2012; 59(113):292-5. PubMed ID: 21940357
[TBL] [Abstract][Full Text] [Related]
35. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
[TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development.
Li Y; Huang G; Diakur J; Wiebe LI
Curr Drug Deliv; 2008 Oct; 5(4):299-302. PubMed ID: 18855599
[TBL] [Abstract][Full Text] [Related]
37. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection.
Schindl MJ; Redhead DN; Fearon KC; Garden OJ; Wigmore SJ;
Gut; 2005 Feb; 54(2):289-96. PubMed ID: 15647196
[TBL] [Abstract][Full Text] [Related]
38. Significance of portal hemodynamic investigation in prediction of hepatic functional reserve in patients with hepatocellular carcinoma undergoing operative treatment.
Yin XY; Lu MD; Huang JF; Liang LJ
Hepatogastroenterology; 2001; 48(42):1701-4. PubMed ID: 11813604
[TBL] [Abstract][Full Text] [Related]
39. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
[TBL] [Abstract][Full Text] [Related]
40. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
